FGF2 and central nervous system cancer: Collectively, our novel findings clarify an association between oncogenic YAP and radioresistance, suggesting that targeting of the YAP–FGF2–MAPK pathway by AZD4547 may have a therapeutic value for glioma patients by restoring radiosensitivity and inducing glioma cell death after radiation.